Lipomics Technologies Overview

  • Founded
  • 2000
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Lipomics Technologies General Information


Provider of metabolite profiling, biomarker discovery and metabolism consultation services. The company develops diagnostic tests for important measures of metabolic function. It provides metabolic assessments for drug research, clinical diagnostics and personalized medicine. It uses its technologies to discover new diagnostic biomarkers, improve drug discovery, develop companion diagnostics.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Diagnostic Equipment
Medical Supplies
Primary Office
  • 3410 Industrial Boulevard
  • Suite 103
  • West Sacramento, CA 95691
  • United States
+1 (916) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lipomics Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 01-Aug-2012 Completed Generating Revenue
5. Merger/Acquisition 18-Sep-2008 00.000 Completed Generating Revenue
4. Convertible Debt 09-Apr-2008 00000 00.000 Completed Generating Revenue
3. Later Stage VC (Series D) 24-May-2007 00.000 00.000 Completed Generating Revenue
2. Convertible Debt 23-Oct-2006 $585K $2.76M Completed Generating Revenue
1. Later Stage VC (Series C) 01-Dec-2003 $2.17M $2.17M Completed Startup
To view Lipomics Technologies’s complete valuation and funding history, request access »

Lipomics Technologies Board Members (6)

Name Representing Role Since
Anula Jayasuriya Ph.D Self Board Member 000 0000
Michael Miille Ph.D Self Board Member 000 0000
Paul Billings Self Board Member 000 0000
Roger Salquist Self Board Member 000 0000
Scott Lenet Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Lipomics Technologies Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Draper Fisher Jurvetson Management Venture Capital Minority 000 0000 000000 0
Vencore Capital Venture Capital Minority 000 0000 000000 0
To view Lipomics Technologies’s complete investors history, request access »